[1]
CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The New England journal of medicine. 1987 Jun 4:316(23):1429-35
[PubMed PMID: 2883575]
Level 3 (low-level) evidence
[2]
Swedberg K,Kjekshus J, Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The American journal of cardiology. 1988 Jul 11
[PubMed PMID: 2839019]
Level 3 (low-level) evidence
[3]
SOLVD Investigators, Yusuf S, Pitt B, Davis CE, Hood WB, Cohn JN. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The New England journal of medicine. 1991 Aug 1:325(5):293-302
[PubMed PMID: 2057034]
[4]
Kjekshus J,Swedberg K, Enalapril for congestive heart failure. The American journal of cardiology. 1989 Feb 21
[PubMed PMID: 2537563]
[5]
Marre M, Chatellier G, Leblanc H, Guyene TT, Menard J, Passa P. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ (Clinical research ed.). 1988 Oct 29:297(6656):1092-5
[PubMed PMID: 2848604]
[6]
Todd PA, Goa KL. Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertension. Drugs. 1992 Mar:43(3):346-81
[PubMed PMID: 1374319]
[9]
Gibbs CR, Lip GY, Beevers DG. Angioedema due to ACE inhibitors: increased risk in patients of African origin. British journal of clinical pharmacology. 1999 Dec:48(6):861-5
[PubMed PMID: 10594491]
[10]
Brown NJ, Ray WA, Snowden M, Griffin MR. Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clinical pharmacology and therapeutics. 1996 Jul:60(1):8-13
[PubMed PMID: 8689816]
[11]
Kostis JB, Kim HJ, Rusnak J, Casale T, Kaplan A, Corren J, Levy E. Incidence and characteristics of angioedema associated with enalapril. Archives of internal medicine. 2005 Jul 25:165(14):1637-42
[PubMed PMID: 16043683]
[12]
Schmidt TD, McGrath KM. Angiotensin-converting enzyme inhibitor angioedema of the intestine: a case report and review of the literature. The American journal of the medical sciences. 2002 Aug:324(2):106-8
[PubMed PMID: 12186104]
Level 3 (low-level) evidence
[13]
Oudit G, Girgrah N, Allard J. ACE inhibitor-induced angioedema of the intestine: Case report, incidence, pathophysiology, diagnosis and management. Canadian journal of gastroenterology = Journal canadien de gastroenterologie. 2001 Dec:15(12):827-32
[PubMed PMID: 11773949]
Level 3 (low-level) evidence
[14]
Duerr M, Glander P, Diekmann F, Dragun D, Neumayer HH, Budde K. Increased incidence of angioedema with ACE inhibitors in combination with mTOR inhibitors in kidney transplant recipients. Clinical journal of the American Society of Nephrology : CJASN. 2010 Apr:5(4):703-8. doi: 10.2215/CJN.07371009. Epub 2010 Jan 21
[PubMed PMID: 20093343]
[15]
Charmillon A, Deibener J, Kaminsky P, Louis G. Angioedema induced by angiotensin converting enzyme inhibitors, potentiated by m-TOR inhibitors: successful treatment with icatibant. Intensive care medicine. 2014 Jun:40(6):893-4. doi: 10.1007/s00134-014-3290-z. Epub 2014 Apr 16
[PubMed PMID: 24737261]
[16]
Todd P, Levison D, Farthing MJ. Enalapril-related cholestatic jaundice. Journal of the Royal Society of Medicine. 1990 Apr:83(4):271-2
[PubMed PMID: 2342045]
[17]
Waeber B, Nussberger J, Brunner HR. Self poisoning with enalapril. British medical journal (Clinical research ed.). 1984 Jan 28:288(6413):287-8
[PubMed PMID: 6318878]
[19]
Nguyen QT, Anderson SR, Sanders L, Nguyen LD. Managing hypertension in the elderly: a common chronic disease with increasing age. American health & drug benefits. 2012 May:5(3):146-53
[PubMed PMID: 24991317]
[20]
Reardon LC, Macpherson DS. Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry? Archives of internal medicine. 1998 Jan 12:158(1):26-32
[PubMed PMID: 9437375]
[21]
Raebel MA. Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Cardiovascular therapeutics. 2012 Jun:30(3):e156-66. doi: 10.1111/j.1755-5922.2010.00258.x. Epub 2011 Jan 26
[PubMed PMID: 21883995]